Kiichi Fujii
Kiichi Fujii publishes mostly in Organic Chemistry, Molecular Biology and Materials Chemistry, on topics such as Phenothiazines and Benzothiazines Synthesis and Activities, Synthesis and Reactivity of Heterocycles and Synthesis and Characterization of Heterocyclic Compounds.
- World rank
- #7,140,680 of 7,710,434 ranked researchers
- Rank in United States
- #1,586,605 of 1,627,098
- Works
- 21
- Citations
- 91
- Citations per work
- 4.3
What does Kiichi Fujii research?
Kiichi Fujii's work is mostly in Chemistry (61%), Biochemistry, Genetics and Molecular Biology (28%), Medicine (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences1464.9%
- Chemistry1361.4%
- Materials Science13.5%
- Life Sciences629.9%
- Health Sciences13.6%
- Medicine13.6%
- 1Organic Chemistry61% of their works
- 2Molecular Biology28% of their works
- 3Materials Chemistry4% of their works
- 4Pharmacology2% of their works
- 5Biochemistry2% of their works
- 6Pharmacology2% of their works
Research topics
- Phenothiazines and Benzothiazines Synthesis and Activities
- Synthesis and Reactivity of Heterocycles
- Synthesis and Characterization of Heterocyclic Compounds
- Quinazolinone synthesis and applications
- Chemical Synthesis and Analysis
- Synthesis and Reactivity of Sulfur-Containing Compounds
- Synthesis and biological activity
- Chemical Reaction Mechanisms
Which keywords describe Kiichi Fujii's research?
The keywords of their largest research topics: Synthesis, Anticancer, Antimicrobial, Biological Evaluation, Molecular Docking, Biological Activities, Phenothiazines and Drug Discovery.
- Medicinal Chemistry
- Acidity Scales
- Thioamides
- Foldamers
- Indirubin
- Scaffold
- Indolizines
- Heterocyclic Compounds
- Drug Discovery
- Biological Activities
- Biological Evaluation
- Anticancer
- Synthesis
- Antimicrobial
- Molecular Docking
- Phenothiazines
- Heterocycles
- Bioactivity
- Organic Synthesis
- Triazines
- Quinazoline
- Peptide Synthesis
- Thionation
- Anticancer Agents
- Nucleophilicity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Synthesis294 topics
- Anticancer223 topics
- Antimicrobial223 topics
- Biological Evaluation183 topics
- Molecular Docking132 topics
- Biological Activities111 topic
- Phenothiazines111 topic
- Drug Discovery102 topics
- Heterocycles102 topics
- Heterocyclic Compounds102 topics
- Bioactivity71 topic
- Indolizines71 topic
- Organic Synthesis72 topics
- Scaffold61 topic
- Triazines61 topic
- Indirubin51 topic
- Quinazoline51 topic
- Foldamers41 topic
- Peptide Synthesis41 topic
- Thioamides41 topic
- Thionation41 topic
- Acidity Scales31 topic
- Anticancer Agents31 topic
- Medicinal Chemistry31 topic
- Nucleophilicity31 topic
Where does Kiichi Fujii work?
Kiichi Fujii's main affiliation in the publication record is Tanabe Research Laboratories, United States.
How many publications and citations does Kiichi Fujii have?
OpenAlex counts 21 works and 91 citations for Kiichi Fujii, an h-index of 6, ranking #7,140,680 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kiichi Fujii. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.